Answers are grounded in this paper and cite their sources.
Molecular foundation models, pre-trained on millions of chemical structures, are increasingly promoted as a universal solution for pharmaceutical prediction tasks. Their appeal lies in the possibility that large-scale chemical pretraining can reduce dependence on small, noisy, task-specific datasets. Despite their rapid proliferation, critical examination of their pretraining data, leakage risks, transferability, and validation practices remains limited and fragmented. This is problematic becaus
No takes yet. Share an insight, caveat, or question.
Hugo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: